(Q36349694)

13 August 2017

1 reference

title

Noninvasive delivery technologies: respiratory delivery of vaccines (English)

1 reference

13 August 2017

Vincent J Sullivan

1

1 reference

13 August 2017

John A Mikszta

2

1 reference

13 August 2017

Philippe Laurent

3

1 reference

13 August 2017

Juan Huang

4

1 reference

13 August 2017

Brandi Ford

5

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

Expert Opinion on Drug Delivery

13 August 2017

1 reference

13 August 2017

3

1 reference

13 August 2017

87-95

1 reference

13 August 2017

1

1 reference

Commercial challenges of protein drug delivery

13 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

21 January 2018

Antigen delivery systems

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Overcoming skin's barrier: the search for effective and user-friendly drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Delivery of bioactive peptides and proteins across oral (buccal) mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Drug delivery via the mucous membranes of the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Key drivers behind the development of global vaccine market.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Mucosal immunity and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Drug delivery to the nasal cavity: in vitro and in vivo assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Inhalation therapy: new delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Non-oral formulations of triptans and their use in acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Dry powder inhalation as a potential delivery method for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Alternative routes of insulin delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Clinical pharmacokinetics and pharmacodynamics of inhaled insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Alternative routes of measles immunization: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

A powder formulation of measles vaccine for aerosol delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Chitosan as a novel nasal delivery system for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Recent developments in adjuvants for vaccines against infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

Recent advances in the discovery and delivery of vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.1.87

21 January 2018

Identifiers

DOI

10.1517/17425247.3.1.87

1 reference

13 August 2017

1 reference